Cite
HARVARD Citation
Isenberg, D. (2019). Comment on: 'Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand et al. Annals of the rheumatic diseases. 78 (11), p. e121. [Online].